$62.69
+6.6%Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.
Chief Financial Officer
Compensation
$506,667
Chief Operating Officer
Chief Technology Officer
Co-Founder & Executive Chairman
Compensation
$500,000
Co-Founder, Chief Executive Officer & Director
Compensation
$506,900
Director of Compliance
Finance & Head of Investor Relations
President
Compensation
$379,688
Secretary & Vice President of Legal
Senior Vice President of Sales & Strategy
During the last 12 months, insiders have sold $47.67M worth of HNGE shares, with no buying activity reported.
0
0.00
376.0K
18.69M
-18.7M
-$18.69M
0
0.00
483.6K
21.73M
-21.7M
-$21.73M
0
0.00
152.8K
7.25M
-7.3M
-$7.25M
0
0.00
0
0.00
+0
+$0
No buying activity
Perez Daniel Antonio
Director, 10 Percent Owner, Officer: Ceo & Co-Founder
$28.45M
Mecklenburg Gabriel M.I.
Director, Other: Exec. Chairman & Co-Founder
$9.86M
Insight Holdings Group, Llc
10 Percent Owner
$6.26M
Budge James
Officer: Chief Financial Officer
$1.81M
Pursley James
Officer: President
$1.03M
Strong bearish signal with $47.67M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
HNGE - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 17, 2026 | June 03, 2026 | 2026 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.